The balance of biogenic amines as condition for normal behaviour
Identifieur interne : 000852 ( Main/Corpus ); précédent : 000851; suivant : 000853The balance of biogenic amines as condition for normal behaviour
Auteurs : W. Birkmayer ; W. Danielczyk ; E. Neumayer ; P. RiedererSource :
- Journal of Neural Transmission [ 0300-9564 ] ; 1972-06-01.
Abstract
Summary: An accumulation of norepinephrin, serotonin and dopamin exists in the brainstem. A decrease of biogenic amines in the brains of Parkinson's cases has been demonstrated. A substitution by the precursor L-DOPA produces an increase of dopamin in the brain and a decrease of serotonin. The high level of dopamin improves the akinesia and the depletion of serotonin causes a toxic delir. A substitution by l-tryptophan restores the balance and the Dopa-psychosis disappears.
Url:
DOI: 10.1007/BF01260902
Links to Exploration step
ISTEX:F377EC34708C70F8E98E7629BE5B9D6A6312579DLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The balance of biogenic amines as condition for normal behaviour</title><author><name sortKey="Birkmayer, W" sort="Birkmayer, W" uniqKey="Birkmayer W" first="W." last="Birkmayer">W. Birkmayer</name><affiliation><mods:affiliation>Ludwig-Boltzmann-Institut für Neurochemie und neurologische Abteilung des Alterskrankenhauses der Stadt Wien-Lainz, Österreich</mods:affiliation></affiliation></author><author><name sortKey="Danielczyk, W" sort="Danielczyk, W" uniqKey="Danielczyk W" first="W." last="Danielczyk">W. Danielczyk</name><affiliation><mods:affiliation>Ludwig-Boltzmann-Institut für Neurochemie und neurologische Abteilung des Alterskrankenhauses der Stadt Wien-Lainz, Österreich</mods:affiliation></affiliation></author><author><name sortKey="Neumayer, E" sort="Neumayer, E" uniqKey="Neumayer E" first="E." last="Neumayer">E. Neumayer</name><affiliation><mods:affiliation>Ludwig-Boltzmann-Institut für Neurochemie und neurologische Abteilung des Alterskrankenhauses der Stadt Wien-Lainz, Österreich</mods:affiliation></affiliation></author><author><name sortKey="Riederer, P" sort="Riederer, P" uniqKey="Riederer P" first="P." last="Riederer">P. Riederer</name><affiliation><mods:affiliation>Ludwig-Boltzmann-Institut für Neurochemie und neurologische Abteilung des Alterskrankenhauses der Stadt Wien-Lainz, Österreich</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:F377EC34708C70F8E98E7629BE5B9D6A6312579D</idno><date when="1972" year="1972">1972</date><idno type="doi">10.1007/BF01260902</idno><idno type="url">https://api.istex.fr/document/F377EC34708C70F8E98E7629BE5B9D6A6312579D/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000852</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The balance of biogenic amines as condition for normal behaviour</title><author><name sortKey="Birkmayer, W" sort="Birkmayer, W" uniqKey="Birkmayer W" first="W." last="Birkmayer">W. Birkmayer</name><affiliation><mods:affiliation>Ludwig-Boltzmann-Institut für Neurochemie und neurologische Abteilung des Alterskrankenhauses der Stadt Wien-Lainz, Österreich</mods:affiliation></affiliation></author><author><name sortKey="Danielczyk, W" sort="Danielczyk, W" uniqKey="Danielczyk W" first="W." last="Danielczyk">W. Danielczyk</name><affiliation><mods:affiliation>Ludwig-Boltzmann-Institut für Neurochemie und neurologische Abteilung des Alterskrankenhauses der Stadt Wien-Lainz, Österreich</mods:affiliation></affiliation></author><author><name sortKey="Neumayer, E" sort="Neumayer, E" uniqKey="Neumayer E" first="E." last="Neumayer">E. Neumayer</name><affiliation><mods:affiliation>Ludwig-Boltzmann-Institut für Neurochemie und neurologische Abteilung des Alterskrankenhauses der Stadt Wien-Lainz, Österreich</mods:affiliation></affiliation></author><author><name sortKey="Riederer, P" sort="Riederer, P" uniqKey="Riederer P" first="P." last="Riederer">P. Riederer</name><affiliation><mods:affiliation>Ludwig-Boltzmann-Institut für Neurochemie und neurologische Abteilung des Alterskrankenhauses der Stadt Wien-Lainz, Österreich</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of Neural Transmission</title><title level="j" type="sub">Basic neurosciences and genetics, Parkinson's disease and allied conditions, Alzheimer's disease and related disorders, biological psychiatry</title><title level="j" type="abbrev">J. Neural Transmission</title><idno type="ISSN">0300-9564</idno><idno type="eISSN">1435-1463</idno><imprint><publisher>Springer-Verlag</publisher><pubPlace>Vienna</pubPlace><date type="published" when="1972-06-01">1972-06-01</date><biblScope unit="volume">33</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="163">163</biblScope><biblScope unit="page" to="178">178</biblScope></imprint><idno type="ISSN">0300-9564</idno></series><idno type="istex">F377EC34708C70F8E98E7629BE5B9D6A6312579D</idno><idno type="DOI">10.1007/BF01260902</idno><idno type="ArticleID">Art5</idno><idno type="ArticleID">BF01260902</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0300-9564</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Summary: An accumulation of norepinephrin, serotonin and dopamin exists in the brainstem. A decrease of biogenic amines in the brains of Parkinson's cases has been demonstrated. A substitution by the precursor L-DOPA produces an increase of dopamin in the brain and a decrease of serotonin. The high level of dopamin improves the akinesia and the depletion of serotonin causes a toxic delir. A substitution by l-tryptophan restores the balance and the Dopa-psychosis disappears.</div></front></TEI><istex><corpusName>springer</corpusName><author><json:item><name>W. Birkmayer</name><affiliations><json:string>Ludwig-Boltzmann-Institut für Neurochemie und neurologische Abteilung des Alterskrankenhauses der Stadt Wien-Lainz, Österreich</json:string></affiliations></json:item><json:item><name>W. Danielczyk</name><affiliations><json:string>Ludwig-Boltzmann-Institut für Neurochemie und neurologische Abteilung des Alterskrankenhauses der Stadt Wien-Lainz, Österreich</json:string></affiliations></json:item><json:item><name>E. Neumayer</name><affiliations><json:string>Ludwig-Boltzmann-Institut für Neurochemie und neurologische Abteilung des Alterskrankenhauses der Stadt Wien-Lainz, Österreich</json:string></affiliations></json:item><json:item><name>P. Riederer</name><affiliations><json:string>Ludwig-Boltzmann-Institut für Neurochemie und neurologische Abteilung des Alterskrankenhauses der Stadt Wien-Lainz, Österreich</json:string></affiliations></json:item></author><articleId><json:string>Art5</json:string><json:string>BF01260902</json:string></articleId><language><json:string>eng</json:string></language><abstract>Summary: An accumulation of norepinephrin, serotonin and dopamin exists in the brainstem. A decrease of biogenic amines in the brains of Parkinson's cases has been demonstrated. A substitution by the precursor L-DOPA produces an increase of dopamin in the brain and a decrease of serotonin. The high level of dopamin improves the akinesia and the depletion of serotonin causes a toxic delir. A substitution by l-tryptophan restores the balance and the Dopa-psychosis disappears.</abstract><qualityIndicators><score>5.302</score><pdfVersion>1.3</pdfVersion><pdfPageSize>432 x 648 pts</pdfPageSize><refBibsNative>false</refBibsNative><keywordCount>0</keywordCount><abstractCharCount>478</abstractCharCount><pdfWordCount>4426</pdfWordCount><pdfCharCount>27588</pdfCharCount><pdfPageCount>16</pdfPageCount><abstractWordCount>73</abstractWordCount></qualityIndicators><title>The balance of biogenic amines as condition for normal behaviour</title><genre><json:string>research-article</json:string></genre><host><volume>33</volume><pages><last>178</last><first>163</first></pages><issn><json:string>0300-9564</json:string></issn><issue>2</issue><subject><json:item><value>Pharmacology/Toxicology</value></json:item><json:item><value>Neurology</value></json:item><json:item><value>Psychiatry</value></json:item></subject><journalId><json:string>702</json:string></journalId><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1435-1463</json:string></eissn><title>Journal of Neural Transmission</title><publicationDate>1972</publicationDate><copyrightDate>1972</copyrightDate></host><publicationDate>1972</publicationDate><copyrightDate>1972</copyrightDate><doi><json:string>10.1007/BF01260902</json:string></doi><id>F377EC34708C70F8E98E7629BE5B9D6A6312579D</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/F377EC34708C70F8E98E7629BE5B9D6A6312579D/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/F377EC34708C70F8E98E7629BE5B9D6A6312579D/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/F377EC34708C70F8E98E7629BE5B9D6A6312579D/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">The balance of biogenic amines as condition for normal behaviour</title><respStmt xml:id="ISTEX-API" resp="Références bibliographiques récupérées via GROBID" name="ISTEX-API (INIST-CNRS)"></respStmt></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Springer-Verlag</publisher><pubPlace>Vienna</pubPlace><availability><p>SPRINGER</p></availability><date>1972-07-03</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">The balance of biogenic amines as condition for normal behaviour</title><author><persName><forename type="first">W.</forename><surname>Birkmayer</surname></persName><affiliation>Ludwig-Boltzmann-Institut für Neurochemie und neurologische Abteilung des Alterskrankenhauses der Stadt Wien-Lainz, Österreich</affiliation></author><author><persName><forename type="first">W.</forename><surname>Danielczyk</surname></persName><affiliation>Ludwig-Boltzmann-Institut für Neurochemie und neurologische Abteilung des Alterskrankenhauses der Stadt Wien-Lainz, Österreich</affiliation></author><author><persName><forename type="first">E.</forename><surname>Neumayer</surname></persName><affiliation>Ludwig-Boltzmann-Institut für Neurochemie und neurologische Abteilung des Alterskrankenhauses der Stadt Wien-Lainz, Österreich</affiliation></author><author><persName><forename type="first">P.</forename><surname>Riederer</surname></persName><affiliation>Ludwig-Boltzmann-Institut für Neurochemie und neurologische Abteilung des Alterskrankenhauses der Stadt Wien-Lainz, Österreich</affiliation></author></analytic><monogr><title level="j">Journal of Neural Transmission</title><title level="j" type="sub">Basic neurosciences and genetics, Parkinson's disease and allied conditions, Alzheimer's disease and related disorders, biological psychiatry</title><title level="j" type="abbrev">J. Neural Transmission</title><idno type="JournalID">702</idno><idno type="pISSN">0300-9564</idno><idno type="eISSN">1435-1463</idno><idno type="IssueArticleCount">5</idno><idno type="VolumeIssueCount">4</idno><imprint><publisher>Springer-Verlag</publisher><pubPlace>Vienna</pubPlace><date type="published" when="1972-06-01"></date><biblScope unit="volume">33</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="163">163</biblScope><biblScope unit="page" to="178">178</biblScope></imprint></monogr><idno type="istex">F377EC34708C70F8E98E7629BE5B9D6A6312579D</idno><idno type="DOI">10.1007/BF01260902</idno><idno type="ArticleID">Art5</idno><idno type="ArticleID">BF01260902</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1972-07-03</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Summary: An accumulation of norepinephrin, serotonin and dopamin exists in the brainstem. A decrease of biogenic amines in the brains of Parkinson's cases has been demonstrated. A substitution by the precursor L-DOPA produces an increase of dopamin in the brain and a decrease of serotonin. The high level of dopamin improves the akinesia and the depletion of serotonin causes a toxic delir. A substitution by l-tryptophan restores the balance and the Dopa-psychosis disappears.</p></abstract><textClass><keywords scheme="Journal Subject"><list><head>Medicine & Public Health</head><item><term>Pharmacology/Toxicology</term></item><item><term>Neurology</term></item><item><term>Psychiatry</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1972-07-03">Created</change><change when="1972-06-01">Published</change><change xml:id="refBibs-istex" who="#ISTEX-API" when="2016-3-2">References added</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/F377EC34708C70F8E98E7629BE5B9D6A6312579D/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Springer, Publisher found" wicri:toSee="no header"><istex:xmlDeclaration>version="1.0" encoding="UTF-8"</istex:xmlDeclaration><istex:docType PUBLIC="-//Springer-Verlag//DTD A++ V2.4//EN" URI="http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd" name="istex:docType"></istex:docType><istex:document><Publisher><PublisherInfo><PublisherName>Springer-Verlag</PublisherName><PublisherLocation>Vienna</PublisherLocation></PublisherInfo><Journal><JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered"><JournalID>702</JournalID><JournalPrintISSN>0300-9564</JournalPrintISSN><JournalElectronicISSN>1435-1463</JournalElectronicISSN><JournalTitle>Journal of Neural Transmission</JournalTitle><JournalSubTitle>Basic neurosciences and genetics, Parkinson's disease and allied conditions, Alzheimer's disease and related disorders, biological psychiatry</JournalSubTitle><JournalAbbreviatedTitle>J. Neural Transmission</JournalAbbreviatedTitle><JournalSubjectGroup><JournalSubject Type="Primary">Medicine & Public Health</JournalSubject><JournalSubject Type="Secondary">Pharmacology/Toxicology</JournalSubject><JournalSubject Type="Secondary">Neurology</JournalSubject><JournalSubject Type="Secondary">Psychiatry</JournalSubject></JournalSubjectGroup></JournalInfo><Volume><VolumeInfo VolumeType="Regular" TocLevels="0"><VolumeIDStart>33</VolumeIDStart><VolumeIDEnd>33</VolumeIDEnd><VolumeIssueCount>4</VolumeIssueCount></VolumeInfo><Issue IssueType="Regular"><IssueInfo TocLevels="0"><IssueIDStart>2</IssueIDStart><IssueIDEnd>2</IssueIDEnd><IssueArticleCount>5</IssueArticleCount><IssueHistory><CoverDate><DateString>1972</DateString><Year>1972</Year><Month>6</Month></CoverDate></IssueHistory><IssueCopyright><CopyrightHolderName>Springer-Verlag</CopyrightHolderName><CopyrightYear>1972</CopyrightYear></IssueCopyright></IssueInfo><Article ID="Art5"><ArticleInfo Language="En" ArticleType="OriginalPaper" NumberingStyle="Unnumbered" TocLevels="0" ContainsESM="No"><ArticleID>BF01260902</ArticleID><ArticleDOI>10.1007/BF01260902</ArticleDOI><ArticleSequenceNumber>5</ArticleSequenceNumber><ArticleTitle Language="En">The balance of biogenic amines as condition for normal behaviour</ArticleTitle><ArticleFirstPage>163</ArticleFirstPage><ArticleLastPage>178</ArticleLastPage><ArticleHistory><RegistrationDate><Year>2005</Year><Month>2</Month><Day>17</Day></RegistrationDate><Received><Year>1972</Year><Month>7</Month><Day>3</Day></Received></ArticleHistory><ArticleCopyright><CopyrightHolderName>Springer-Verlag</CopyrightHolderName><CopyrightYear>1972</CopyrightYear></ArticleCopyright><ArticleGrants Type="Regular"><MetadataGrant Grant="OpenAccess"></MetadataGrant><AbstractGrant Grant="OpenAccess"></AbstractGrant><BodyPDFGrant Grant="Restricted"></BodyPDFGrant><BodyHTMLGrant Grant="Restricted"></BodyHTMLGrant><BibliographyGrant Grant="Restricted"></BibliographyGrant><ESMGrant Grant="Restricted"></ESMGrant></ArticleGrants><ArticleContext><JournalID>702</JournalID><VolumeIDStart>33</VolumeIDStart><VolumeIDEnd>33</VolumeIDEnd><IssueIDStart>2</IssueIDStart><IssueIDEnd>2</IssueIDEnd></ArticleContext></ArticleInfo><ArticleHeader><AuthorGroup><Author AffiliationIDS="Aff1" PresentAffiliationID="Aff1"><AuthorName DisplayOrder="Western"><GivenName>W.</GivenName><FamilyName>Birkmayer</FamilyName></AuthorName></Author><Author AffiliationIDS="Aff1" PresentAffiliationID="Aff1"><AuthorName DisplayOrder="Western"><GivenName>W.</GivenName><FamilyName>Danielczyk</FamilyName></AuthorName></Author><Author AffiliationIDS="Aff1" PresentAffiliationID="Aff1"><AuthorName DisplayOrder="Western"><GivenName>E.</GivenName><FamilyName>Neumayer</FamilyName></AuthorName></Author><Author AffiliationIDS="Aff1" PresentAffiliationID="Aff1"><AuthorName DisplayOrder="Western"><GivenName>P.</GivenName><FamilyName>Riederer</FamilyName></AuthorName></Author><Affiliation ID="Aff1"><OrgName>Ludwig-Boltzmann-Institut für Neurochemie und neurologische Abteilung des Alterskrankenhauses der Stadt Wien-Lainz</OrgName><OrgAddress><Country>Österreich</Country></OrgAddress></Affiliation></AuthorGroup><Abstract ID="Abs1" Language="En"><Heading>Summary</Heading><Para>An accumulation of norepinephrin, serotonin and dopamin exists in the brainstem. A decrease of biogenic amines in the brains of Parkinson's cases has been demonstrated. A substitution by the precursor L-DOPA produces an increase of dopamin in the brain and a decrease of serotonin. The high level of dopamin improves the akinesia and the depletion of serotonin causes a toxic delir. A substitution by l-tryptophan restores the balance and the Dopa-psychosis disappears.</Para></Abstract></ArticleHeader><NoBody></NoBody></Article></Issue></Volume></Journal></Publisher></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>The balance of biogenic amines as condition for normal behaviour</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>The balance of biogenic amines as condition for normal behaviour</title></titleInfo><name type="personal"><namePart type="given">W.</namePart><namePart type="family">Birkmayer</namePart><affiliation>Ludwig-Boltzmann-Institut für Neurochemie und neurologische Abteilung des Alterskrankenhauses der Stadt Wien-Lainz, Österreich</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">W.</namePart><namePart type="family">Danielczyk</namePart><affiliation>Ludwig-Boltzmann-Institut für Neurochemie und neurologische Abteilung des Alterskrankenhauses der Stadt Wien-Lainz, Österreich</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Neumayer</namePart><affiliation>Ludwig-Boltzmann-Institut für Neurochemie und neurologische Abteilung des Alterskrankenhauses der Stadt Wien-Lainz, Österreich</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Riederer</namePart><affiliation>Ludwig-Boltzmann-Institut für Neurochemie und neurologische Abteilung des Alterskrankenhauses der Stadt Wien-Lainz, Österreich</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="research-article" displayLabel="OriginalPaper"></genre><originInfo><publisher>Springer-Verlag</publisher><place><placeTerm type="text">Vienna</placeTerm></place><dateCreated encoding="w3cdtf">1972-07-03</dateCreated><dateIssued encoding="w3cdtf">1972-06-01</dateIssued><copyrightDate encoding="w3cdtf">1972</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract lang="en">Summary: An accumulation of norepinephrin, serotonin and dopamin exists in the brainstem. A decrease of biogenic amines in the brains of Parkinson's cases has been demonstrated. A substitution by the precursor L-DOPA produces an increase of dopamin in the brain and a decrease of serotonin. The high level of dopamin improves the akinesia and the depletion of serotonin causes a toxic delir. A substitution by l-tryptophan restores the balance and the Dopa-psychosis disappears.</abstract><relatedItem type="host"><titleInfo><title>Journal of Neural Transmission</title><subTitle>Basic neurosciences and genetics, Parkinson's disease and allied conditions, Alzheimer's disease and related disorders, biological psychiatry</subTitle></titleInfo><titleInfo type="abbreviated"><title>J. Neural Transmission</title></titleInfo><genre type="Journal" displayLabel="Archive Journal"></genre><originInfo><dateIssued encoding="w3cdtf">1972-06-01</dateIssued><copyrightDate encoding="w3cdtf">1972</copyrightDate></originInfo><subject><genre>Medicine & Public Health</genre><topic>Pharmacology/Toxicology</topic><topic>Neurology</topic><topic>Psychiatry</topic></subject><identifier type="ISSN">0300-9564</identifier><identifier type="eISSN">1435-1463</identifier><identifier type="JournalID">702</identifier><identifier type="IssueArticleCount">5</identifier><identifier type="VolumeIssueCount">4</identifier><part><date>1972</date><detail type="volume"><number>33</number><caption>vol.</caption></detail><detail type="issue"><number>2</number><caption>no.</caption></detail><extent unit="pages"><start>163</start><end>178</end></extent></part><recordInfo><recordOrigin>Springer-Verlag, 1972</recordOrigin></recordInfo></relatedItem><identifier type="istex">F377EC34708C70F8E98E7629BE5B9D6A6312579D</identifier><identifier type="DOI">10.1007/BF01260902</identifier><identifier type="ArticleID">Art5</identifier><identifier type="ArticleID">BF01260902</identifier><accessCondition type="use and reproduction" contentType="copyright">Springer-Verlag</accessCondition><recordInfo><recordContentSource>SPRINGER</recordContentSource><recordOrigin>Springer-Verlag, 1972</recordOrigin></recordInfo></mods></metadata><enrichments><istex:refBibTEI uri="https://api.istex.fr/document/F377EC34708C70F8E98E7629BE5B9D6A6312579D/enrichments/refBib"><teiHeader></teiHeader><text><front></front><body></body><back><listBibl><biblStruct xml:id="b0"><analytic><title level="a" type="main">Symposium Bel-Air IV., Gen~ve~ Sept</title><author><persName><forename type="first">A ; ~uriaguerra</forename></persName></author><author><persName><forename type="first">J</forename><surname>De</surname></persName></author></analytic><monogr><title level="m">Monoamines Noyaux gris centraux et Syndrome de Parkinson</title><meeting><address><addrLine>Paris</addrLine></address></meeting><imprint><publisher>Masson. 197I</publisher><date type="published" when="1970"></date><biblScope unit="page" from="327" to="353"></biblScope></imprint></monogr></biblStruct><biblStruct xml:id="b1"><analytic><title level="a" type="main">Gaddurn: The distribution of 5 OH tryptamin and substance P in the central nervous system</title><author><persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Amin</surname></persName></author><author><persName><forename type="first">T</forename><forename type="middle">B B</forename><surname>Crawford</surname></persName></author><author><persName><forename type="first">J</forename><forename type="middle">U</forename></persName></author></analytic><monogr><title level="j">Abstr. XIX int. physiol. Congr</title><imprint><biblScope unit="page">165</biblScope><date type="published" when="1953"></date></imprint></monogr></biblStruct><biblStruct xml:id="b2"><analytic><title level="a" type="main">On the Occurence of Homovanillic Acid in Brain and Cerebrospinal Fluid and its Determination by a Fluorornetric Method</title><author><persName><forename type="first">N</forename><forename type="middle">E</forename><surname>And~n</surname></persName></author><author><persName><forename type="first">B</forename><forename type="middle">E</forename><surname>Ross</surname></persName></author><author><persName><forename type="first">B</forename><surname>Werdinim</surname></persName></author></analytic><monogr><title level="j">Life Science</title><imprint><biblScope unit="volume">7</biblScope><biblScope unit="page">448</biblScope><date type="published" when="1963"></date></imprint></monogr></biblStruct><biblStruct xml:id="b3"><analytic><title level="a" type="main">Wahnsyndrome im Verlauf des encephalitischen Parkinson</title><author><persName><forename type="first">M</forename><surname>Anderson</surname></persName></author><author><persName><forename type="first">G</forename><surname>Guerra</surname></persName></author></analytic><monogr><title level="j">Rass. Neuropsychlatr</title><imprint><biblScope unit="volume">5</biblScope><biblScope unit="page" from="22" to="44"></biblScope></imprint></monogr></biblStruct><biblStruct xml:id="b4"><analytic><title level="a" type="main">McDougalb: 5-Hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatr, neurol, diseases</title><author><persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Ashcrofl</surname></persName></author><author><persName><forename type="first">T</forename><forename type="middle">B B</forename><surname>Crawford</surname></persName></author><author><persName><forename type="first">D</forename><surname>Ecdeston</surname></persName></author><author><persName><forename type="first">D</forename><surname>Sharman</surname></persName></author><author><persName><forename type="first">D</forename><forename type="middle">F</forename></persName></author></analytic><monogr><title level="j">Lancet II</title><imprint><biblScope unit="page" from="1049" to="1052"></biblScope></imprint></monogr></biblStruct><biblStruct xml:id="b5"><monogr><title></title><author><persName><forename type="first">W</forename><surname>Birkmayer</surname></persName></author><author><persName><forename type="first">W</forename><surname>Danielczyk</surname></persName></author><author><persName><forename type="first">E</forename><surname>Neumayer</surname></persName></author><author><persName><forename type="first">P</forename><surname>Riederer</surname></persName></author><imprint></imprint></monogr></biblStruct><biblStruct xml:id="b6"><analytic><title level="a" type="main">Drug-induced Changes m the Concentration of 5-OR Indolyl Compounds in Cerebrospinal Fluid and Caudate Nucleus</title><author><persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Ashcrofl</surname></persName></author><author><persName><forename type="first">D</forename></persName></author><author><persName><forename type="first">F</forename><surname>Sharman</surname></persName></author></analytic><monogr><title level="j">Brit. J. Pharmacot</title><imprint><biblScope unit="volume">19</biblScope><biblScope unit="issue">153</biblScope><biblScope unit="page">160</biblScope><date type="published" when="1962"></date></imprint></monogr></biblStruct><biblStruct xml:id="b7"><analytic><title level="a" type="main">L-DOPA therapy in Parkinson's disease: a critical review of nine years' experience</title><author><persName><forename type="first">A</forename><surname>Barbeau</surname></persName></author></analytic><monogr><title level="j">Cana& Med. Assoc</title><imprint><biblScope unit="volume">101</biblScope><biblScope unit="page" from="791" to="800"></biblScope><date type="published" when="1969"></date></imprint></monogr></biblStruct><biblStruct xml:id="b8"><analytic><title level="a" type="main">Increase of cerebral catecholamines by 3,4-dihydroxyphenylatanine afLer Inhibition of peripheral decarboxylase</title><author><persName><forename type="first">G</forename><surname>Bartholini</surname></persName></author><author><persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Bates</surname></persName></author><author><persName><forename type="first">W</forename><forename type="middle">P</forename><surname>Burkhard</surname></persName></author><author><persName><forename type="first">A</forename><surname>Pletscher</surname></persName></author></analytic><monogr><title level="j">Nature</title><imprint><biblScope unit="volume">852</biblScope><biblScope unit="page" from="215" to="853"></biblScope><date type="published" when="1967"></date></imprint></monogr></biblStruct><biblStruct xml:id="b9"><analytic><title level="a" type="main">Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylase</title><author><persName><forename type="first">G</forename><surname>Bartholini</surname></persName></author><author><persName><forename type="first">M</forename><surname>Da</surname></persName></author><author><persName><forename type="first">A</forename><surname>Prada</surname></persName></author><author><persName><surname>Pletscher</surname></persName></author></analytic><monogr><title level="j">J. Pharm. Pharmac</title><imprint><biblScope unit="volume">20</biblScope><biblScope unit="page" from="228" to="229"></biblScope><date type="published" when="1968"></date></imprint></monogr></biblStruct><biblStruct xml:id="b10"><analytic><title level="a" type="main">Verteilung des 5-hydroxytryptamins (Serotonin) im Gehirn des Menschen und sein Verhalten bei Patienten mit Parkinsonsyndrom</title><author><persName><forename type="first">H</forename><surname>Bernheimer</surname></persName></author><author><persName><forename type="first">W</forename><surname>Birkmayer</surname></persName></author><author><persName><forename type="first">O</forename><surname>Hornyhiewicz</surname></persName></author></analytic><monogr><title level="j">Klin. Ws&r</title><imprint><biblScope unit="volume">39</biblScope><biblScope unit="page" from="1056" to="1059"></biblScope><date type="published" when="1961"></date></imprint></monogr></biblStruct><biblStruct xml:id="b11"><analytic><title></title><author><persName><forename type="first">H</forename><surname>Bernheimer</surname></persName></author><author><persName><forename type="first">W</forename><surname>Birkmayer</surname></persName></author><author><persName><forename type="first">O</forename><surname>Hornykiewicz</surname></persName></author></analytic><monogr><title level="j">Zur Biochemie & Parkinson-Syndroms des Menschen. Klin. Wschr</title><imprint><biblScope unit="volume">41</biblScope><biblScope unit="page" from="465" to="469"></biblScope><date type="published" when="1963"></date></imprint></monogr></biblStruct><biblStruct xml:id="b12"><analytic><title></title><author><persName><forename type="first">W</forename><surname>Birkmayer</surname></persName></author><author><persName><forename type="first">O</forename><surname>Hornykiewicz</surname></persName></author></analytic><monogr><title level="m">Der L-Dioxyphenylalanin (L-DOPA) Effekt bei der Parkinson-Akinese</title><imprint><date type="published" when="1961"></date><biblScope unit="page" from="787" to="788"></biblScope></imprint></monogr></biblStruct><biblStruct xml:id="b13"><analytic><title></title><author><persName><forename type="first">W</forename><surname>Birkmayer</surname></persName></author><author><persName><forename type="first">O</forename><surname>Hornykiewicz</surname></persName></author></analytic><monogr><title level="m">Der L-Dioxyphenylalanin (L-DOPA) Effekt beim Parkinsonsyndrom des Menschen</title><imprint><date type="published" when="1962"></date><biblScope unit="page" from="560" to="574"></biblScope></imprint></monogr></biblStruct><biblStruct xml:id="b14"><analytic><title level="a" type="main">Experimentelle Befunde und neue Aspekte bei extrapyramidalen Erkrankungen</title><author><persName><forename type="first">W</forename><surname>Birkmayer</surname></persName></author></analytic><monogr><title level="j">Wien. Z. f. Nervenheilk</title><imprint><biblScope unit="volume">23</biblScope><biblScope unit="page" from="128" to="139"></biblScope><date type="published" when="1966"></date></imprint></monogr></biblStruct><biblStruct xml:id="b15"><analytic><title level="a" type="main">Die Bedeutung des Monoamin-Metabolismus ftir die Pathologie des extrapyramidalen Systems</title><author><persName><forename type="first">W</forename><surname>Birkmayer</surname></persName></author></analytic><monogr><title level="j">Ars medici</title><imprint><biblScope unit="volume">57</biblScope><biblScope unit="issue">814</biblScope><biblScope unit="page">825</biblScope><date type="published" when="1967"></date></imprint></monogr></biblStruct><biblStruct xml:id="b16"><analytic><title></title><author><persName><forename type="first">W</forename><surname>Birkmayer</surname></persName></author><author><persName><forename type="first">M</forename></persName></author></analytic><monogr><title level="m">Mentasth Weitere experimentelle Untersu&ungen tiber den CatechoIaminstoffwechsel bei extrapyramidalen Erkrankungen Arch</title><imprint><date type="published" when="1967"></date><biblScope unit="page">35</biblScope></imprint></monogr></biblStruct><biblStruct xml:id="b17"><analytic><title level="a" type="main">Biochemistry of Depression in Parkinson's Disease</title><author><persName><forename type="first">W</forename><surname>Birkmayer</surname></persName></author></analytic><monogr><title level="m">L-DOPA and Parkinsonism</title><editor>Barbeau, A., and F. H. McDowell</editor><meeting><address><addrLine>Philadelphia</addrLine></address></meeting><imprint><date type="published" when="1970"></date><biblScope unit="page" from="341" to="342"></biblScope></imprint></monogr></biblStruct><biblStruct xml:id="b18"><analytic><title level="a" type="main">St/Srung des gyrosin-und Tryptophanmetabolimus bei Depression</title><author><persName><forename type="first">W</forename><surname>Birkmayer</surname></persName></author><author><persName><forename type="first">W</forename><surname>Linauer</surname></persName></author></analytic><monogr><title level="j">Arch. Psychiatr. Nervenkr</title><imprint><biblScope unit="volume">213</biblScope><biblScope unit="page" from="377" to="387"></biblScope><date type="published" when="1970"></date></imprint></monogr></biblStruct><biblStruct xml:id="b19"><analytic><title level="a" type="main">10 Jahre L-DOPA Therapie des Parkinsonsyndroms</title><author><persName><forename type="first">W</forename><surname>Birkmayer</surname></persName></author></analytic><monogr><title level="j">Wien. klin. Wschr</title><imprint><biblScope unit="volume">83</biblScope><biblScope unit="page" from="221" to="227"></biblScope><date type="published" when="1971"></date></imprint></monogr></biblStruct><biblStruct xml:id="b20"><monogr><title></title><author><persName><forename type="first">W</forename><surname>Er</surname></persName></author><author><persName><forename type="first">W</forename><surname>Danidczyk</surname></persName></author><author><persName><forename type="first">E</forename><surname>Neumayer</surname></persName></author><author><persName><forename type="first">P</forename><surname>Riederer</surname></persName></author><imprint></imprint></monogr><note>(. In press.</note></biblStruct><biblStruct xml:id="b21"><analytic><title level="a" type="main">Zum Verst~indnis gewisser psychischer Ver~inderungen bei Kranken mit Parkinsonschem Symptomenkomplex</title><author><persName><forename type="first">A</forename><surname>Bostroem</surname></persName></author></analytic><monogr><title level="j">Z. ges. NeuroI, Psvchiat</title><imprint><biblScope unit="volume">76</biblScope><biblScope unit="page" from="444" to="460"></biblScope><date type="published" when="1922"></date></imprint></monogr></biblStruct><biblStruct xml:id="b22"><analytic><title></title><author><persName><forename type="first">W</forename><forename type="middle">E</forename><surname>Bunney</surname></persName></author><author><persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Janowsky</surname></persName></author><author><persName><forename type="first">F</forename><forename type="middle">K</forename><surname>Goodwin</surname></persName></author><author><persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Davis</surname></persName></author><author><persName><forename type="first">M</forename><forename type="middle">K H</forename><surname>Brodie</surname></persName></author><author><persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Murphy</surname></persName></author><author><persName><forename type="first">T</forename><forename type="middle">N</forename><surname>Chase</surname></persName></author></analytic><monogr><title level="m">Effect of L-DOPA on depression</title><imprint><date type="published" when="1969"></date><biblScope unit="page" from="885" to="886"></biblScope></imprint></monogr></biblStruct><biblStruct xml:id="b23"><analytic><title level="a" type="main">Schizophrene Psychosen bei Encephalitis lethargica The Balance of Biogenic Amines as Condition for Normal Behaviour 177</title><author><persName><forename type="first">H</forename><surname>Biirger</surname></persName></author><author><persName><forename type="first">W</forename><surname>Mayer-Gross</surname></persName></author></analytic><monogr><title level="j">Z. Neurol. Psychiat</title><imprint><biblScope unit="volume">106</biblScope><biblScope unit="page" from="438" to="482"></biblScope><date type="published" when="1926"></date></imprint></monogr></biblStruct><biblStruct xml:id="b24"><analytic><title></title><author><persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Calne</surname></persName></author><author><persName><forename type="first">A</forename><forename type="middle">S D</forename><surname>Spiers</surname></persName></author><author><persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Stern</surname></persName></author><author><persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Laurence</surname></persName></author><author><persName><forename type="first">R</forename><surname>Armitoge</surname></persName></author></analytic><monogr><title level="m">L-DOPA in idiopathic parkinsonism</title><imprint><date type="published" when="1969"></date><biblScope unit="page" from="973" to="976"></biblScope></imprint></monogr></biblStruct><biblStruct xml:id="b25"><analytic><title level="a" type="main">On the presence of 3-hydroxytyramine in brain</title><author><persName><forename type="first">A</forename><surname>Carlsson</surname></persName></author><author><persName><forename type="first">M</forename><surname>Lindqvist</surname></persName></author><author><persName><forename type="first">T</forename><surname>Magnusson</surname></persName></author><author><persName><forename type="first">B</forename><surname>Waldeck</surname></persName></author></analytic><monogr><title level="j">Science</title><imprint><biblScope unit="volume">127</biblScope><biblScope unit="page" from="471" to="473"></biblScope><date type="published" when="1958"></date></imprint></monogr></biblStruct><biblStruct xml:id="b26"><analytic><title level="a" type="main">Psychosis and other psychiatric manifestations of levodopa therapy</title><author><persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Celesia</surname></persName></author><author><persName><forename type="first">A: N</forename><surname>Barr</surname></persName></author></analytic><monogr><title level="j">Arch. Neurol</title><imprint><biblScope unit="volume">23</biblScope><biblScope unit="page" from="193" to="200"></biblScope><date type="published" when="1970"></date></imprint></monogr></biblStruct><biblStruct xml:id="b27"><analytic><title level="a" type="main">Parkinsonism, L-DOPA and mental depression</title><author><persName><forename type="first">M</forename><surname>Cherrington</surname></persName></author></analytic><monogr><title level="j">J. Americ. Geriat. Soc</title><imprint><biblScope unit="volume">18</biblScope><biblScope unit="page" from="513" to="516"></biblScope><date type="published" when="1970"></date></imprint></monogr></biblStruct><biblStruct xml:id="b28"><analytic><title level="a" type="main">Some aspects of the psychic and behavioral effects of L-DOPA Philadelplxia: Fa. Davis Tryptamine metabolism in depression</title><author><persName><forename type="first">W</forename><forename type="middle">G</forename><surname>Clark</surname></persName></author><author><persName><forename type="first">D</forename><forename type="middle">M</forename><surname>_11</surname></persName></author><author><persName><forename type="first">A</forename><surname>Shaw</surname></persName></author><author><persName><forename type="first">E</forename><surname>Mallerson</surname></persName></author><author><persName><forename type="first">G</forename><surname>Eccleston</surname></persName></author><author><persName><surname>Gundy</surname></persName></author></analytic><monogr><title level="j">Coppen, Brit. J.Psychiat</title><editor>L-DOPA and Parkinsonism (Barbeau, A., and F. H. McDowell</editor><imprint><biblScope unit="volume">111</biblScope><biblScope unit="page" from="349" to="357993"></biblScope><date type="published" when="1965"></date></imprint></monogr></biblStruct><biblStruct xml:id="b29"><analytic><title></title><author><persName><forename type="first">_A</forename><surname>Coppen</surname></persName></author><author><persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Shaw</surname></persName></author><author><persName><forename type="first">B</forename><surname>Herzberg</surname></persName></author><author><persName><forename type="first">R</forename><surname>Maggs</surname></persName></author></analytic><monogr><title level="m">Tryptophan in the treatment of depression</title><imprint><date type="published" when="1967"></date><biblScope unit="page" from="1178" to="1180"></biblScope></imprint></monogr></biblStruct><biblStruct xml:id="b30"><analytic><title level="a" type="main">Aromatic amino acids and modification of parkinsonism. New Eng</title><author><persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Otzias</surname></persName></author><author><persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Van Woert</surname></persName></author><author><persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Schiffer</surname></persName></author></analytic><monogr><title level="j">J. Med</title><imprint><biblScope unit="volume">276</biblScope><biblScope unit="page" from="374" to="379"></biblScope><date type="published" when="1967"></date></imprint></monogr></biblStruct><biblStruct xml:id="b31"><analytic><title level="a" type="main">Modification of parkinsonism: chronic treatment with L-DOPA. New Eng</title><author><persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Cotzias</surname></persName></author><author><persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Papavasiliou</surname></persName></author><author><persName><forename type="first">R</forename><surname>Gel&n</surname></persName></author></analytic><monogr><title level="j">J. Med</title><imprint><biblScope unit="volume">280</biblScope><biblScope unit="page" from="337" to="345"></biblScope><date type="published" when="1969"></date></imprint></monogr></biblStruct><biblStruct xml:id="b32"><analytic><title></title><author><persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Damasio</surname></persName></author><author><persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Antunes</surname></persName></author><author><persName><forename type="first">C</forename><surname>Macedo</surname></persName></author></analytic><monogr><title level="m">L-DOPA, Parkinsonism and Depression</title><imprint><date type="published" when="1970"></date><biblScope unit="page" from="611" to="612"></biblScope></imprint></monogr></biblStruct><biblStruct xml:id="b33"><analytic><title level="a" type="main">Uber halluzinatorisch-paranoide Bilder bei Metencephalitis</title><author><persName><forename type="first">E</forename><surname>Dornarus</surname></persName></author></analytic><monogr><title level="j">Arch. Psychiatr</title><imprint><biblScope unit="volume">78</biblScope><biblScope unit="page" from="558" to="570"></biblScope><date type="published" when="1926"></date></imprint></monogr></biblStruct><biblStruct xml:id="b34"><monogr><title level="m" type="main">Die Encephalitis lethargica, ihre Nachkrankheiten und ihre Behandlung</title><author><persName><forename type="first">C</forename><forename type="middle">V</forename><surname>Econorno</surname></persName></author><imprint><date type="published" when="1929"></date><publisher>Urban & Schwarzenberg</publisher><pubPlace>Wien</pubPlace></imprint></monogr></biblStruct><biblStruct xml:id="b35"><analytic><title level="a" type="main">Verteilung yon Noradrenalin und Dopamin (3-Hydroxytryptamin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems</title><author><persName><forename type="first">H</forename><surname>Ehringer</surname></persName></author><author><persName><forename type="first">O</forename><surname>Hornykiewicz</surname></persName></author></analytic><monogr><title level="j">Klin. Wschr</title><imprint><biblScope unit="volume">38</biblScope><biblScope unit="page" from="1236" to="1240"></biblScope><date type="published" when="1960"></date></imprint></monogr></biblStruct><biblStruct xml:id="b36"><analytic><title level="a" type="main">A specific Sympathomimetic Ergone in Adrenergic Nerve Fibres and its Relations to Adrenaline and Nor Adrenaline</title><author><persName><forename type="first">V</forename><forename type="middle">S</forename><surname>Euler</surname></persName></author></analytic><monogr><title level="j">Acta Physiol. Scand</title><imprint><biblScope unit="volume">12</biblScope><biblScope unit="page" from="73" to="97"></biblScope><date type="published" when="1946"></date></imprint></monogr></biblStruct><biblStruct xml:id="b37"><analytic><title level="a" type="main">Borcherding: L-DOPA: Effect on Concentrations of Dopamine, Norepinephrine and Serotonin in Brains of Mice</title><author><persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Everett</surname></persName></author><author><persName><forename type="first">J</forename><forename type="middle">W</forename></persName></author></analytic><monogr><title level="j">Science</title><imprint><biblScope unit="volume">6</biblScope><biblScope unit="page" from="849" to="850"></biblScope><date type="published" when="1970"></date></imprint></monogr></biblStruct><biblStruct xml:id="b38"><analytic><title level="a" type="main">Administration of a peripheral decarboxylase inhibitor with L-DOPA to depressed patients</title><author><persName><forename type="first">F</forename><forename type="middle">K</forename><surname>Goodwfn</surname></persName></author><author><persName><forename type="first">H</forename><forename type="middle">K H</forename><surname>Brodie</surname></persName></author><author><persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Murphy</surname></persName></author><author><persName><forename type="first">W</forename><forename type="middle">E</forename><surname>Bunney</surname></persName></author></analytic><monogr><title level="j">Lance~ I</title><imprint><biblScope unit="page" from="908" to="911"></biblScope><date type="published" when="1970"></date></imprint></monogr></biblStruct><biblStruct xml:id="b39"><analytic><title level="a" type="main">Psychiatric Side Effects of Levodopa in Man</title><author><persName><forename type="first">F</forename><forename type="middle">K</forename><surname>Goodwin</surname></persName></author></analytic><monogr><title level="j">JAMA</title><imprint><biblScope unit="volume">218</biblScope><biblScope unit="page" from="1915" to="1919"></biblScope><date type="published" when="1971"></date></imprint></monogr></biblStruct><biblStruct xml:id="b40"><analytic><title level="a" type="main">Mental symptoms in Parkinsonian patients treated with L-DOPA</title><author><persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Jenkins</surname></persName></author><author><persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Groh</surname></persName></author></analytic><monogr><title level="j">Lancet II</title><imprint><biblScope unit="page" from="177" to="180"></biblScope><date type="published" when="1970"></date></imprint></monogr></biblStruct><biblStruct xml:id="b41"><analytic><title level="a" type="main">Zur Psychopathologie der Paralysis agitans</title><author><persName><forename type="first">H</forename><surname>K6nig</surname></persName></author></analytic><monogr><title level="j">Arch. Psychiatr</title><imprint><biblScope unit="volume">50</biblScope><biblScope unit="page" from="285" to="305"></biblScope><date type="published" when="1912"></date></imprint></monogr></biblStruct><biblStruct xml:id="b42"><analytic><title level="a" type="main">Die Dissoziation der Schlafkomponenten beim Parkinsonsyndrom</title><author><persName><forename type="first">H</forename><surname>Lenz</surname></persName></author></analytic><monogr><title level="j">Arch. Psychiatr</title><imprint><biblScope unit="volume">194</biblScope><biblScope unit="page" from="550" to="559"></biblScope><date type="published" when="1956"></date></imprint></monogr></biblStruct><biblStruct xml:id="b43"><analytic><title level="a" type="main">Partielle Schlafzust~inde mit Halluzinationen belm Parkinson</title><author><persName><forename type="first">K</forename><surname>Leonhard</surname></persName></author></analytic><monogr><title level="j">Z. Neut</title><imprint><biblScope unit="volume">131</biblScope><biblScope unit="page" from="234" to="264"></biblScope><date type="published" when="1931"></date></imprint></monogr></biblStruct><biblStruct xml:id="b44"><analytic><title level="a" type="main">l~ber die Differentialdiagnose metencephalitischer und schizophrener Sttirungen</title><author><persName><forename type="first">E</forename><surname>Leyser</surname></persName></author></analytic><monogr><title level="j">Z. Neut</title><imprint><biblScope unit="volume">99</biblScope><biblScope unit="issue">I929</biblScope><biblScope unit="page" from="424" to="438"></biblScope></imprint></monogr></biblStruct><biblStruct xml:id="b45"><analytic><title level="a" type="main">Syndrome de la calotte du p6doncule c6rdbraI</title><author><persName><forename type="first">J</forename><surname>Lherrnitte</surname></persName></author></analytic><monogr><title level="j">Rev. neuroL</title><imprint><biblScope unit="volume">38</biblScope><biblScope unit="page" from="1359" to="1365"></biblScope></imprint></monogr><note>t922</note></biblStruct><biblStruct xml:id="b46"><analytic><title></title><author><persName><forename type="first">S</forename><surname>Matitz</surname></persName></author><author><persName><forename type="first">M</forename><surname>Kanzler</surname></persName></author></analytic><monogr><title level="m">L-DOPA-Behavioural Effects. In: Ajuriaguerra , J. de: Symposium Bet-Air IV. Monoamines noyauX gris centrauX et Syndrome de Parkinson</title><meeting><address><addrLine>Paris</addrLine></address></meeting><imprint><publisher>Masson</publisher><date type="published" when="1971"></date><biblScope unit="page" from="467" to="484"></biblScope></imprint></monogr></biblStruct><biblStruct xml:id="b47"><analytic><title level="a" type="main">Les troubles psychiques chez les parkinsoniens</title><author><persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Mallid</surname></persName></author></analytic><monogr><title level="j">Th~se Bordeaux</title><imprint><date type="published" when="1908"></date></imprint></monogr></biblStruct><biblStruct xml:id="b48"><analytic><title></title><author><persName><forename type="first">N</forename><surname>Matussek</surname></persName></author><author><persName><forename type="first">O</forename><surname>Benkert</surname></persName></author><author><persName><forename type="first">K</forename><surname>Schneider</surname></persName></author><author><persName><forename type="first">H</forename><surname>Otten</surname></persName></author><author><persName><forename type="first">H</forename><surname>Pohlrneier</surname></persName></author></analytic><monogr><title level="m">L-DOPA plus Decarboxylase Inhibitor in Depression</title><imprint><date type="published" when="1970"></date><biblScope unit="page" from="660" to="661"></biblScope></imprint></monogr></biblStruct><biblStruct xml:id="b49"><analytic><title level="a" type="main">Treatment of Parkinson's syndrome with L-dihydroxyphenylalanine (levodopa)</title><author><persName><forename type="first">F</forename><surname>Mcdowell</surname></persName></author><author><persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Lee</surname></persName></author><author><persName><forename type="first">T</forename><surname>Swift</surname></persName></author><author><persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Sweet</surname></persName></author><author><persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Ogsbury</surname></persName></author><author><persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Kessler</surname></persName></author></analytic><monogr><title level="j">Ann. Intern. Med</title><imprint><biblScope unit="volume">72</biblScope><biblScope unit="page" from="29" to="35"></biblScope><date type="published" when="1970"></date></imprint></monogr></biblStruct><biblStruct xml:id="b50"><analytic><title level="a" type="main">Double-blind placebo-controlled study of levodopa therapy in Parklnson's disease</title><author><persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Meunter</surname></persName></author></analytic><monogr><title level="j">Neurology</title><imprint><biblScope unit="volume">20</biblScope><biblScope unit="page" from="6" to="13"></biblScope><date type="published" when="1970"></date></imprint></monogr></biblStruct><biblStruct xml:id="b51"><analytic><title level="a" type="main">Kopin: L-DOPA,induced release of cerebral: monoamines</title><author><persName><forename type="first">K</forename><forename type="middle">Y</forename><surname>Ng</surname></persName></author><author><persName><forename type="first">T</forename><forename type="middle">N</forename><surname>Chase</surname></persName></author><author><persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Coburn</surname></persName></author><author><persName><forename type="first">I</forename><forename type="middle">J</forename></persName></author></analytic><monogr><title level="j">Science</title><imprint><biblScope unit="volume">170</biblScope><biblScope unit="page" from="76" to="77"></biblScope></imprint></monogr><note>i970</note></biblStruct><biblStruct xml:id="b52"><analytic><title level="a" type="main">Mental Effects of High-Dosage-Levodopa</title><author><persName><forename type="first">O '</forename><surname>Brien</surname></persName></author><author><persName><forename type="first">C</forename><forename type="middle">P</forename></persName></author><author><persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Digiacomo</surname></persName></author><author><persName><forename type="first">S</forename><surname>Fahn</surname></persName></author><author><persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Schwarz</surname></persName></author></analytic><monogr><title level="j">Arch. Gen. Psychiat</title><imprint><biblScope unit="volume">24</biblScope><biblScope unit="page" from="6" to="64"></biblScope></imprint></monogr></biblStruct><biblStruct xml:id="b53"><analytic><title level="a" type="main">The catecholamine hypothesis of affective disorders</title><author><persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Schildkraut</surname></persName></author></analytic><monogr><title level="j">Amer. J. Psychiat</title><imprint><biblScope unit="volume">123</biblScope><biblScope unit="page" from="508" to="522"></biblScope><date type="published" when="1965"></date></imprint></monogr></biblStruct><biblStruct xml:id="b54"><analytic><title level="a" type="main">Traitement du Parkinsonisme avec la L-DOPA associ6e k un inhibiteur de la decarboxylase</title><author><persName><forename type="first">J</forename><surname>Siegfried</surname></persName></author></analytic><monogr><title level="j">M6d. et Hyg</title><imprint><biblScope unit="volume">27</biblScope><biblScope unit="page" from="543" to="545"></biblScope><date type="published" when="1969"></date></imprint></monogr></biblStruct><biblStruct xml:id="b55"><analytic><title level="a" type="main">Double-blind comparison of levodopa and procyclidine in Parkinsonism</title><author><persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Tirnberlake</surname></persName></author></analytic><monogr><title level="j">Neurology</title><imprint><biblScope unit="volume">20</biblScope><biblScope unit="page" from="31" to="35"></biblScope><date type="published" when="1970"></date></imprint></monogr></biblStruct><biblStruct xml:id="b56"><monogr><title level="m" type="main">Therapeutique du syndrome de Parkinson par Ia L-DOPA "per os" associ6e ~ un inhibiteur de la d~carboxylase (Ro 4-4602) Press m~d</title><author><persName><forename type="first">R</forename><surname>Tissot</surname></persName></author><author><persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Gailiard</surname></persName></author><author><persName><forename type="first">M</forename><surname>Guggisberg</surname></persName></author><author><persName><forename type="first">G</forename><surname>Gauthier</surname></persName></author><author><persName><forename type="first">J</forename><surname>Ajuriaguerra</surname></persName></author><imprint><date type="published" when="1969"></date><biblScope unit="page" from="616" to="622"></biblScope></imprint></monogr></biblStruct><biblStruct xml:id="b57"><analytic><title level="a" type="main">Serotonin Content of some Mammalian Tissues and Urine and a Method for its Determination</title><author><persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Twarog</surname></persName></author><author><persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Page</surname></persName></author></analytic><monogr><title level="j">J. Physiol</title><imprint><biblScope unit="volume">75</biblScope><biblScope unit="page" from="157" to="161"></biblScope><date type="published" when="1953"></date></imprint></monogr></biblStruct><biblStruct xml:id="b58"><analytic><title level="a" type="main">The concentration of sympathin in different parts of the central nervous System</title><author><persName><forename type="first">M</forename><surname>Vogt</surname></persName></author></analytic><monogr><title level="j">J. Physiol</title><imprint><biblScope unit="volume">123</biblScope><biblScope unit="page" from="451" to="481"></biblScope><date type="published" when="1954"></date></imprint></monogr></biblStruct><biblStruct xml:id="b59"><analytic><title level="a" type="main">Treatment of Park insonism with levodopa</title><author><persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Yahr</surname></persName></author><author><persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Duvoisin</surname></persName></author><author><persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Schear</surname></persName></author><author><persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Barret</surname></persName></author><author><persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Hoehn</surname></persName></author></analytic><monogr><title level="j">Arch. NeuroL (Chic.)</title><imprint><biblScope unit="volume">21</biblScope><biblScope unit="page" from="343" to="354"></biblScope><date type="published" when="1969"></date></imprint></monogr></biblStruct><biblStruct xml:id="b60"><monogr><title></title><author><persName><surname>Prof</surname></persName></author><author><persName><forename type="first">W</forename><surname>Dr</surname></persName></author><author><persName><surname>Birkmayer</surname></persName></author><author><persName><forename type="middle">W</forename><surname>Dr</surname></persName></author><author><persName><surname>Danielczyk</surname></persName></author><author><persName><forename type="middle">E</forename><surname>Dr</surname></persName></author><author><persName><forename type="first">Dr. P '</forename><surname>Neumayer</surname></persName></author><author><persName><surname>Riederer</surname></persName></author><imprint><publisher>Ludwig-Boltzmann-Institut far Neurochemie</publisher><pubPlace>A-I130 Wien, Osterreich</pubPlace></imprint></monogr></biblStruct><biblStruct xml:id="b61"><analytic><title level="a" type="main">A-i011 Wiem~ Far den Textteil verantwortIich: Dr. Wilhelm SchwabI, M~lkerbastel 5, A~I:011 Wien. Fiir den Arizeigenteil verantwortlich: Bruno Schweder, SchweizertalstraBe 8mt0~ A-1130 Wien</title><author><persName><forename type="first">Eigentiimer</forename><surname>Herausgeber</surname></persName></author><author><persName><surname>Verieger</surname></persName></author></analytic><monogr><title level="j">Dru&: R. Spies & Co</title><imprint><publisher>Springer-Verlag</publisher><publisher>Springer-Verlag</publisher><biblScope unit="volume">5</biblScope></imprint></monogr><note>Printed. in Austria</note></biblStruct></listBibl></back></text></istex:refBibTEI></enrichments><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000852 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000852 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:F377EC34708C70F8E98E7629BE5B9D6A6312579D
|texte= The balance of biogenic amines as condition for normal behaviour
}}
| This area was generated with Dilib version V0.6.23. |  |